• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification

    Magnesium: An Essential Mineral with Many Forms and Functions
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Nutrasource Rebrands Clinical Trial Site to Apex Trials

    Kerry Sponsors Upcycled Food Foundation Research Fellowship

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Natural Products Association Blasts FDA for Punting CBD Issues to Congress

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Nutrasource Rebrands Clinical Trial Site to Apex Trials

    Natural Products Association Blasts FDA for Punting CBD Issues to Congress

    Kerry Sponsors Upcycled Food Foundation Research Fellowship

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits

    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels

    CRN Highlights 'Supplement to Savings' Report for National Heart Month
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    EIRICH Machines

    KLK OLEO

    Gencor

    JRS Pharma

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    EIRICH Machines

    KLK OLEO

    Gencor

    JRS Pharma

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Lonza to Acquire Capsugel for $5.5 Billion

    Deal designed to create leading solutions provider in drug development, formulation, delivery technologies and manufacturing.

    Lonza to Acquire Capsugel for $5.5 Billion
    Related CONTENT
    • Gain a competitive edge
    • Get in the game: Join the esports nutrition market
    • Vitafoods Europe 2022 Attendance Returns to 2019 Level
    • Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    • Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits
    12.15.16
    Lonza Group AG, Basel, Switzerland has entered an agreement to acquire Capsugel from the private equity group KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion. The Boards of Directors of both Lonza and Capsugel have approved the transaction.

    The transaction is expected to close in the second quarter of 2017 and is subject to certain regulatory approvals and other customary closing conditions.

    Lonza said the acquisition is in line with its stated strategy to accelerate growth and deliver value along the healthcare continuum by complementing its existing offerings and by opening up new market opportunities in the pharma and consumer healthcare and nutrition industries. With the acquisition of Capsugel, Lonza will add a trusted brand with a large breadth of technologies and will expand the market reach of its contract development and manufacturing organization (CDMO) and products businesses. It will also support Lonza’s strategic ambition of getting closer to the patient and end consumer.

    The acquisition is designed to create a leading integrated, value-added solutions provider in drug development, formulation, delivery technologies and manufacturing for the global pharma and consumer healthcare industries. The combined business will be positioned to benefit from the dynamics in these industries and to anticipate and address technology trends in order to support the evolving needs of its customers, the companies said. It will provide additional value by offering an integrated portfolio of industry-leading technologies, from active pharmaceutical ingredients (APIs) through excipients to dosage forms and delivery technologies.

    Pfizer had previously sold Capsugel to KKR for nearly $2.38 billion in April 2011. Since that time Capsugel acquired a range of companies, including Bend Research Inc., which specializes in bioavailability enhancement, Xcelience, a CDMO, and Powdersize, a contract manufacturer with expertise in particle-size reduction and control technologies, as well as other new dosage technologies.

    Today, with the addition of Capsugel’s oral dosage delivery technologies, including its leading position in hard capsule technologies, Lonza expects to become the partner of choice for its pharma customers along the entire value chain. The combined technologies and offerings will provide customers innovative solutions in both large and small molecules and strengthen Lonza’s ability to support the pharma industry by bringing new, differentiated medicines to market rapidly and efficiently.

    In addition, the acquisition is expected to strengthen Lonza’s position in consumer healthcare and nutrition as Lonza becomes a fully integrated and innovative service provider of active ingredients, oral dosage forms, development services and delivery technologies. As a result, Lonza will be well positioned to meet the increasing need for optimized consumer health and nutrition through a wide offering of next-generation dosage forms. The combined business will also be able to leverage its bioavailability technology to create a new dietary ingredient-ready offering, as well as capitalize on its formulation expertise to develop new ingredients and to market new combination products.

    The enlarged business would have had combined 2015 revenues of approximately CHF 4.8 billion and adjusted EBITDA of approximately CHF 1.1 billion with an enhanced margin profile. Lonza and Capsugel’s highly synergistic customer base and complementary business models will facilitate seamless integration. The combined business will be able to leverage the strong regulatory track record and global footprint of each company.

    With approximately 3,600 employees and 13 facilities on three continents, Capsugel has a customer-centric, entrepreneurial and collaborative culture that aligns with Lonza’s corporate culture. Both companies focus on quality, operational excellence and delivering on promises.

    “The acquisition of Capsugel meets Lonza’s strategic and financial goals,” said Lonza CEO Richard Ridinger. “It accelerates our healthcare continuum strategy by giving us broader exposure to the fast-growing pharma and consumer healthcare markets. We expect the transaction to be accretive to our core earnings per share in the first full year post closing.”

    He explained further, “This new integrated approach will benefit our customers, who will gain from the simplicity and efficiency of working with one company that can provide world-leading support from APIs to excipients and dosage forms. The combined business will allow us to partner with our customers to help them bring highly differentiated products to market more quickly and efficiently.”

    Guido Driesen, president and CEO of Capsugel, said, “This transaction brings together two leading companies that share a common vision—to deliver real value to customers by accelerating their ability to develop and commercialize innovative pharmaceutical and healthcare products. The combination of our complementary technology platforms will put us in a strong position to benefit from evolving trends in the pharma and consumer healthcare markets.”

    He added, “Both companies enjoy a strong quality and regulatory track record, and we believe that the combination enables us to provide the most complete set of tailored and integrated solutions for our customers. We look forward to bringing together our talented teams to deliver science- and engineering-based solutions to customers for the benefit of the patients and consumers who use their products. I am personally committed to making this integration a success.”

    Pete Stavros, member of KKR and head of the Industrials Investing Team, said, “Since acquiring Capsugel five years ago, we have supported Guido and his management team in repositioning the company from a global leader in hard capsules into a specialty CDMO. Capsugel has grown significantly by investing in innovation, strategic acquisitions, product development and geographic expansion. Now Capsugel is well positioned for the next phase of its growth, and we look forward to its continued success as a part of Lonza.”

    Synergies
    The bulk of the benefits resulting from the transaction will be gained from positive top-line and innovation synergies. The highly synergistic customer base, the expanded addressable market and the improved value proposition for the customer will allow Lonza to further leverage its current product and service offerings. Also the acquisition of Capsugel will allow cross-selling of existing products, combine manufacturing solutions and services and create an integrated value offering that merges Lonza’s ingredients with Capsugel’s dosage forms.

    The primary initial focus of this transaction is to ensure a seamless integration while continuing the strong growth trajectory of the Capsugel business. Lonza believes that the step-by-step integration will preserve the strong innovation culture and lead to a combined top-line synergy potential of around CHF 100 million per annum in the mid- to long-term.

    Lonza expects to achieve operating synergies of CHF ~30 million per annum, which are expected to be fully realized by year three, in the areas of corporate, procurement and IT, as well as various efficiency gains. In addition, tax synergies of CHF ~15 million per annum are expected.

    Lonza anticipates that the transaction will be accretive to its CORE Earnings per Share (EPS) from the first full year post closing onwards and intends to retain its current dividend policy.

    Financing and Approvals
    The $5.5 billion all-cash acquisition of Capsugel will be financed with a combination of debt and equity financing. Lonza has committed debt financing for the full acquisition amount from BofA Merrill Lynch and UBS and plans to raise equity, which is fully underwritten by UBS and BofA Merrill Lynch for an amount up to CHF 3.3 billion.

    Lonza’s Board of Directors is currently authorized to increase the share capital through the issuance of 5,000,000 fully paid-in registered shares. Lonza’s Board intends to seek approval for additional share capital at its upcoming annual general meeting (AGM) in April 2017.

    Lonza expects to retain a leverage profile around ~3x net debt/EBITDA at closing and to maintain its unofficial investment-grade credit profile assigned by a number of Swiss banks. Lonza believes that the strong projected cash flow of the combined company will enable rapid de-leveraging after the acquisition and continue to support all planned growth initiatives.

    The financial package foresees the refinancing of Lonza’s current CHF 700 million revolving credit facility.
    Related Searches
    • Dietary Supplements
    • World Markets
    • Mergers & Acquisitions
    • Delivery & Dosage Technologies
    Related Knowledge Center
    • World Markets
    • Delivery & Dosage Technologies
    • Dietary Supplements
    Suggested For You
    Gain a competitive edge Gain a competitive edge
    Get in the game: Join the esports nutrition market Get in the game: Join the esports nutrition market
    Vitafoods Europe 2022 Attendance Returns to 2019 Level Vitafoods Europe 2022 Attendance Returns to 2019 Level
    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits
    Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients Lonza Appoints Christian Seufert as President of Capsules, Health Ingredients
    Lonza’s TWK10 Sports Probiotic Lands in Europe Lonza’s TWK10 Sports Probiotic Lands in Europe
    Lonza Capsules & Health Ingredients to Feature Innovative Clean Label Solutions Lonza Capsules & Health Ingredients to Feature Innovative Clean Label Solutions
    OmniActive Names Adam Adelmann Chief Commercial Officer OmniActive Names Adam Adelmann Chief Commercial Officer
    Beauty Ingredient Formulation Directory Fall 2021 Beauty Ingredient Formulation Directory Fall 2021
    Lonza’s Carniking Premix Shown to Improve Protein Turnover and Energy Expenditure in Dogs Lonza’s Carniking Premix Shown to Improve Protein Turnover and Energy Expenditure in Dogs
    Lonza Debuts Non-GMO ‘Made with Organic Collagen’ UC-II in the U.S. Lonza Debuts Non-GMO ‘Made with Organic Collagen’ UC-II in the U.S.
    Oral Solids: Market & Technology Trends Oral Solids: Market & Technology Trends
    Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations
    Lonza Expands Capsule Manufacturing Capacity Lonza Expands Capsule Manufacturing Capacity

    Related Videos

    • Gain a competitive edge

      Gain a competitive edge

      The esports nutrition opportunity starts here.

    • Get in the game: Join the esports nutrition market

      Get in the game: Join the esports nutrition market

      the esports nutrition products opportunity is Growing! Learn more.

    • Breaking News | Consumer Trends | Healthcare Trends | Industry & Market News | World Markets
      Vitafoods Europe 2022 Attendance Returns to 2019 Level

      Vitafoods Europe 2022 Attendance Returns to 2019 Level

      This year's installation of the event brought in over 15,000 participants from 130 countries.
      05.23.22


    • Breaking News | Delivery & Dosage Technologies | Regulations | Supplier News | World Markets
      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Capsule provides a bright white color while meeting titanium dioxide-free requirements for foods in the EU.
      05.10.22

    • Bone & Joint Health | Breaking News | Proteins, Peptides, Amino Acids | Research News | Sports Nutrition
      Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits

      Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits

      The ingredient, UC-II, showed significant improvements in flexibility and comfort in 96 active, healthy participants.
      04.29.22

    Loading, Please Wait..
    Trending
    • NOW Switches To Bottles Made From 100% Post-Consumer Recycled Resin
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    Breaking News
    • Nutrasource Rebrands Clinical Trial Site to Apex Trials
    • Kerry Sponsors Upcycled Food Foundation Research Fellowship
    • Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    • Vitamin D Supplementation Reduces Risk of Dynapenia
    • Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Nutrasource Rebrands Clinical Trial Site to Apex Trials
    Kerry Sponsors Upcycled Food Foundation Research Fellowship
    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    GE HealthCare, Imricor Team Up for Interventional Cardiac MRI
    Promising Study Results Released for Uncontrolled Hypertension Treatment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    SK bioscience Introduces New Global Partnership Model for Vaccines
    Merck's KEYTRUDA Wins Expanded Approval in Non-Small Cell Lung Cancer
    Bone Biologics Engages Avania for NB1 Clinical Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    LVMH Reports Record 2022
    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Happi

    Latest Breaking News From Happi

    Scott’s Liquid Gold Sells Wood and Floor Care Brands
    Ingredient Platform ClearForMe Expands into Baby Care
    Existing Regulatory Framework for Foods & Supplements Not Appropriate for CBD: FDA
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Major Expansion of TrueVIS Printer Family
    Neos Expands Production Capacity, European Market Presence
    Celanese Launches Nine New Conductive Inks for Consumer Applications
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Channeled Resources launches blank labels with PET liner
    Infigo partners with Four Pees in Benelux region
    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Roche, Sysnav Partner on Movement Tracking Tech for Neuromuscular Disorders
    Orthopedic Braces/Support, Casting/Splints Market to Top $12B by 2030
    Orthofix Launches the Mariner Deformity System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Celanese Launches Nine New Conductive Inks
    NREL Develops Thin, Lightweight Layer for Radiation Barrier for Perovskites in Space
    LG Display Reports Fourth Quarter 2022 Results

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login